Cargando…
Azelnidipine may be a valuable drug for chemoprevention of ESCC with high MEK1/2 levels
Autor principal: | Qian, Haili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676184/ https://www.ncbi.nlm.nih.gov/pubmed/36420305 http://dx.doi.org/10.1016/j.omto.2022.10.008 |
Ejemplares similares
-
Azelnidipine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by targeting MEK1/2
por: Zhao, Lili, et al.
Publicado: (2022) -
Inhibitory Effects of Azelnidipine Tablets on Morning Hypertension
por: Kario, Kazuomi, et al.
Publicado: (2013) -
Azelnidipine protects myocardium in hyperglycemia-induced cardiac damage
por: Kain, Vasundhara, et al.
Publicado: (2010) -
Clinical use of azelnidipine in the treatment of hypertension in Chinese patients
por: Chen, Bi-Lian, et al.
Publicado: (2015) -
A case of complete atrioventricular block with extremely high blood concentration of azelnidipine
por: Ide, Naohito, et al.
Publicado: (2021)